Ferdous A, Gonzalez F, Sun L, Kodadek T, Johnston S A
Departments of Internal Medicine and Biochemistry, Ryburn Center for Molecular Cardiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX7 5390-8573, USA.
Mol Cell. 2001 May;7(5):981-91. doi: 10.1016/s1097-2765(01)00250-7.
It is generally thought that the primary or even sole activity of the 19S regulatory particle of the 26S proteasome is to facilitate the degradation of polyubiquitinated proteins by the 20S-core subunit. However, we present evidence that the 19S complex is required for efficient elongation of RNA polymerase II (RNAP II) in vitro and in vivo. First, yeast strains carrying alleles of SUG1 and SUG2, encoding 19S components, exhibit phenotypes indicative of elongation defects. Second, in vitro transcription is inhibited by antibodies raised against Sug1, or by heat-inactivating temperature-sensitive Sug1 mutants with restoration of elongation by addition of immunopurified 19S complex. Finally, Cdc68, a known elongation factor, coimmunoprecipitates with the 19S complex, indicating a physical interaction. Inhibition of the 20S proteolytic core of the proteasome has no effect on elongation. This work defines a nonproteolytic role for the 19S complex in RNAP II transcription.
人们普遍认为,26S蛋白酶体的19S调节颗粒的主要甚至唯一活动是促进20S核心亚基对多泛素化蛋白的降解。然而,我们提供的证据表明,19S复合物在体外和体内对RNA聚合酶II(RNAP II)的有效延伸是必需的。首先,携带编码19S成分的SUG1和SUG2等位基因的酵母菌株表现出表明延伸缺陷的表型。其次,针对Sug1产生的抗体或通过热灭活温度敏感的Sug1突变体抑制体外转录,通过添加免疫纯化的19S复合物恢复延伸。最后,已知的延伸因子Cdc68与19S复合物共免疫沉淀,表明存在物理相互作用。蛋白酶体的20S蛋白水解核心的抑制对延伸没有影响。这项工作定义了19S复合物在RNAP II转录中的非蛋白水解作用。